Health Care: Drugs

Peregrine Pharmaceuticals Inc (PPHM: NASDAQ)

$1.3 n/a | n/a%
07/02/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.30
52 Week High 1.89
52 Week Low 1.19
Avg. Daily Vol. (Mil) 1.10
Beta (3 year) 1.81
Share Related Items
Mkt Cap (Mil) 244.83
Shares Out (Mil) 188.33
Float (Mil) 178.18
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.20
Current Ratio 2.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 10.22
Price/Book 4.92
Price/Cash Flow -4.80
Per Share Data
Earnings -0.29
Sales 0.13
Book Value 0.26
Cash Flow -0.27
Business Summary
Peregrine Pharmaceuticals Inc is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for treatment & diagnosis of cancer. With its phosphatidylserine-targeting platform, it is pursuing two clinical programs in cancer.
General Information
14282 Franklin Avenue
Tustin, CA 92780
Industry : Drugs
Sector: Health Care
Employees: 180
CEO: Mr. Steven W. King
Short Interest
Current Month (Mil) 9.30
Previous Month (Mil) 10.40
Short Interest Ratio (Days) 5.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -61.30
Return on Investments -97.30
Gross Margin 43.20
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PPHM

Latest PPHM Headlines from TheStreet

More Financial News for PPHM

Press Releases for PPHM

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter